How to Read a Peptide COA (Certificate of Analysis)

The real problem is not reading a COA, it is trusting the lab that issued it

Verifying a peptide COA means confirming the issuing laboratory is independent and accredited, the batch number matches your vial exactly, the HPLC-MS assay reports purity percentage plus identity confirmation against theoretical mass, and the lab can be reached directly to confirm the certificate is genuine before you trust it completely.

Most guides on peptide COAs stop at telling you what to look for on the page: an HPLC percentage here, a mass spec result there. That framing puts the cart before the horse. A skillfully faked COA looks identical to a real one. A genuine COA from an in-house lab carries the same conflict of interest as a restaurant grading its own kitchen. The question that actually protects your research is not what does this document say but who produced this document, and can I verify that independently?

This guide is written for educational purposes and applies to research use only. Any application to human subjects should be supervised by a qualified clinician. The sections below cover how to vet the laboratory behind a COA, how to decode mass-spec purity terminology, how to spot fabricated certificates, and when the paperwork alone is not enough to justify trusting a batch.

Why supplier-issued COAs create a structural problem

A certificate of analysis is supposed to be an objective statement of analytical fact. In the research peptide market, that objectivity is routinely compromised before you even open the document. Most peptide vendors provide certificates of analysis that supposedly verify purity and identity, but these COAs often come from the vendor's own testing, which creates an obvious conflict of interest before a single test result is even printed.

Independent third-party lab validation is impartial in a way in-house testing structurally cannot be, and this distinction matters because the peptide market is largely unregulated: without independent validation, some suppliers offer impure, mislabeled, or counterfeit peptides and there is no external check to catch it. The commercial growth behind this problem is not small. Synthetic peptide therapeutics have expanded into a large and fast-moving market over the past decade, and that growth has outpaced the analytical infrastructure needed to police it consistently (Vlieghe 2010).

The practical consequence is measurable. Measured semaglutide purity from unregulated online sellers has been shown to run as low as 7.7% to 14.37%, far below the 99% claimed on the label, in a study of test-purchased samples (PMC11582493). Every sample in that batch was classified as substandard, falsified, or counterfeit.

The analytical stakes for research integrity are equally high. A study examining peptide samples from five commercial suppliers found that one product was in reality a totally different peptide, and two-thirds of the remaining peptides were below the purity threshold needed for reliable in vitro and in vivo work, with purity under 95% and/or individual impurities exceeding 1% (De et al. 2008). If you are researching BPC-157 gut health effects or running any quantitative assay, impurity profiles of that magnitude invalidate your data before the experiment starts.

Regulators have documented the same pattern from the enforcement side. A Belgian government laboratory built a dedicated LC-MS/MS screening method specifically because customs agencies kept encountering counterfeit and illegal peptide preparations in seized shipments, a problem serious enough to warrant its own detection protocol (Van Wichelen 2015). This is not a fringe concern. It is a documented enforcement category, and it is the reason the peptide purity crisis keeps showing up in the same conversations as counterfeit pharmaceuticals.

How to evaluate the laboratory behind a COA

Before reading a single line of data, your first question should be: who ran this test? The answer determines whether the numbers mean anything at all.

Step 1: Identify the lab name and look it up independently

A legitimate COA carries the full trading name of the testing laboratory, not just a logo. Search for that lab directly. A credible independent testing facility has its own website, contact details, and a list of accreditations you can verify outside of the supplier's portal. A credible COA is signed by an authorized analyst and states which lab performed the testing. If that signature is absent or the lab cannot be found with a basic search, treat the document as unverified.

Step 2: Confirm accreditation status

In the United States, reputable analytical laboratories operate under ISO/IEC 17025 accreditation, CLIA certification, or both. Independent CLIA-certified facilities are the benchmark for legitimate peptide batch testing. Accreditation databases are publicly searchable: A2LA (American Association for Laboratory Accreditation) and NVLAP (National Voluntary Laboratory Accreditation Program) both maintain online registries. If a lab named on a COA does not appear in either, that is a serious verification gap. Note that several labs widely used inside the research peptide community, including some of the most popular verification portals, operate without formal ISO 17025 accreditation. That does not automatically disqualify them, but it means their public verification portal matters more than their letterhead.

Step 3: Contact the laboratory directly to confirm the certificate

Contact the testing lab directly if you have any doubts. A quick email asking whether they issued a specific certificate number takes minimal effort and can reveal fabrication immediately, because legitimate labs will confirm or deny their involvement without hesitation. This single step eliminates the majority of counterfeit COAs in circulation, because a fabricated certificate cannot survive direct verification against the issuing lab's own records. Some independent testing platforms have built this verification step into their workflow. Entering the certificate number or scanning a QR code confirms the test actually occurred on several reputable testing portals. This is the fastest single check you can run, and it takes less time than reading the rest of this article.

What a genuine third-party COA actually contains

Once you have confirmed the lab is real, evaluate the document itself. A real COA from an independent facility has a specific anatomy. The table below maps each section to what a credible entry looks like versus what a fabricated or in-house document typically shows.

COA mass-spec purity terminology, decoded

The vocabulary on a COA is where most readers lose the thread, and vendors count on that. Four terms get used loosely but mean specific, different things.

HPLC purity is a percentage generated by reverse-phase high-performance liquid chromatography. It measures what proportion of the peptide-related material in the vial matches the target peak, using UV detection typically around 214-220 nm. It says nothing about salts, water, or non-peptide contaminants.

Assay (sometimes labeled "peptide content") is a separate percentage describing how much of the actual net peptide mass is present relative to the total vial weight, once you subtract counterions like acetate or trifluoroacetate, residual water, and synthesis solvents. A vial can show 99% HPLC purity and only 75-85% net peptide content once assay accounts for everything else in the powder. This gap is exactly the kind of specification distinction regulatory frameworks like ICH Q6A require labs to report separately rather than folding into one number (ICH Q6A 2000).

Identity confirmation is the job mass spectrometry does. HPLC tells you how much of the sample is a single dominant compound; it cannot tell you what that compound actually is. Two structurally different peptides with similar hydrophobicity can co-elute at the same retention time and look identical on an HPLC trace. Mass spec resolves that by comparing observed molecular weight against the theoretical weight calculated from the peptide's sequence. High-resolution LC-MS methods used in reference-standard work can identify and quantify structurally related peptide impurities that are invisible on a purity chromatogram alone, which is why identity confirmation and purity are reported as two separate lines on a rigorous COA rather than one composite score (Li et al. 2018).

A quick-reference checklist for reading a COA

Run through these points in order every time a new certificate lands in your inbox. This is the sequence, written out, not a form to download.

1. Confirm the lab name is printed in full, is searchable independently, and is not just a logo.
2. Check the batch or lot number on the document against the physical label on your vial. They must match exactly, character for character.
3. Look for a chromatogram image, not just a purity percentage. A number with no visual trace is unverifiable.
4. Confirm the HPLC purity is reported separately from an assay or net-content percentage. If only one number appears, ask which one it is.
5. Find the mass spectrometry section and confirm both the theoretical and observed molecular weight are listed, not just the word "confirmed."
6. Check that the observed mass agrees with the theoretical mass within roughly 0.5 Da, or within a few ppm if the method is high-resolution.
7. Look for an endotoxin result reported in EU/mg or EU/vial, not a bare "pass."
8. Verify the test date is close to the manufacture date, not months or years old.
9. If a QR code or certificate number is present, use it. Confirm the record on the lab's own portal, not just the supplier's page.
10. Email the lab directly if anything above is missing, vague, or inconsistent. A real lab will answer.

How strong is the evidence behind the peptide purity crisis?

The purity failures cited earlier are not a single anecdote. The semaglutide sample study, the five-supplier peptide analysis, and the Belgian customs screening method each independently point at the same structural weakness: unregulated peptide markets produce a measurable rate of substandard or mislabeled product, and supplier paperwork alone does not catch it. That convergence across three separate research contexts (a consumer-purchase audit, a laboratory characterization study, and a regulatory enforcement program) is what makes the pattern credible rather than a single outlier result. Where the evidence is thinner is in translating exact failure rates across different peptide categories; purity failure percentages for semaglutide-class GLP-1 analogs are not automatically the same as failure rates for shorter research peptides like BPC-157 or TB-500, since synthesis complexity differs substantially between them. Treat the specific percentages as evidence of a real, recurring problem category rather than a universal number that applies to every peptide equally.

Common mistakes people make reading a COA

A supplier reusing the exact same COA across multiple batches is one of the most common tells; genuine HPLC results vary slightly batch to batch, so identical 99.9% purity on every listing is a red flag, not reassurance. Another frequent mistake is treating a high HPLC purity number as proof the vial contains the correct peptide; without a matching mass spec identity result, a high purity percentage can describe the wrong compound with total confidence. People also skip checking the batch number against the physical vial, assume a screenshot is equivalent to a verifiable PDF, and accept a bare "endotoxin: pass" without asking for the EU/mg figure. Finally, many researchers stop at the document instead of contacting the lab, even though that single email is the fastest way to catch a fabricated certificate before it ever affects your data.

When paperwork isn't enough: commissioning independent testing

If a supplier's COA fails any step in the checklist above, or if your work depends on tight reproducibility, sending a sample to an independent lab for your own HPLC and mass spec run is the only way to remove the guesswork. This costs money and adds lead time, but for anyone running quantitative work such as a knee cartilage or gut-inflammation protocol where dosing precision matters, that cost is trivial compared to a compromised dataset. Ask the lab for both HPLC purity and mass spec identity confirmation reported separately, plus an endotoxin result if the work involves any immune-sensitive assay.

Who should not rely on document review alone

Anyone running a sensitive in vitro assay where a 1-2% impurity could produce a false signal should not accept COA review as the final check; commission independent verification instead. The same applies to anyone stacking multiple compounds, since an unidentified impurity in one peptide can confound the interpretation of a combined protocol like a BPC-157 and TB-500 stack. This content is educational and intended for research use only; any decision to apply findings to a human protocol should involve a qualified clinician, not a supplier's paperwork.

Vetting your supplier beyond the paperwork

A COA is one input, not the whole picture. Cross-reference the supplier against independent community reporting, check whether their testing lab appears consistently across multiple product lines rather than changing every few months, and look at how transparent they are about batch-to-batch variation. Our recommended sources page lists vendor-neutral criteria we use to evaluate where research peptides come from, separate from any single COA. The regulatory backdrop matters here too. As oversight around the research peptide category continues to shift, understanding the case for tighter peptide regulation gives useful context for why third-party verification currently sits on the buyer rather than a regulator.

Related protocols worth reading next

Once you have a verified peptide in hand, the next practical questions are usually about handling it correctly. Our guide on how to reconstitute peptides covers the mixing and storage steps that a purity result does not. If you are specifically trying to distinguish authentic material from a counterfeit before you even order, our piece on how to know if peptides are real walks through visual and behavioral tells that complement everything in this guide. And if BPC-157 is the peptide in question, our BPC-157 dosing protocol page assumes you have already cleared the verification step covered here.

If you're researching this compound, our recommended sources page lists vendor-neutral criteria for evaluating where research peptides come from. It supports the channel to keep guides like this one free and current.

This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice.